| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―May―06 |
Shedding light on an active principle from the aerial parts of Echinacea purpurea against SARS-CoV-2 in vitro |
Niklas Hofer, Evelyn Wolfram, Corinna Urmann |
| 2 |
[GO] |
2026―Jan―14 |
Harnessing phytoconstituents to treat COVID-19 triggered acute respiratory distress syndrome: Insights from network pharmacology, and molecular modeling |
Pragati Gupta, Kamal Dev, Chirag N. Patel, Gurjot Kaur |
| 3 |
[GO] |
2025―Oct―28 |
Thymol-based heterocyclic derivatives: synthesis and SARS-CoV-2 Mpro molecular docking studies |
Geneive E. Henry, Eden L. Parks |
| 4 |
[GO] |
2025―Oct―28 |
The potential of curry leaf extract in controlling SARS-CoV-2 infectious syndromes |
Mohamed Abbas Umare Faruk, Michal Korinek, Hui-Chun Wang |
| 5 |
[GO] |
2025―Oct―28 |
A steroid-rich fraction from parasitic climber Cocculus hirsutus (L.) W.Theob inhibits coronavirus disease and neutrophilic inflammation |
Vidya Febrasca Tenderly, Thiyagarajan Raviraj, Yen Chi Loo, Olha Mykhailenko, Marcela Safratova, Stefan Kosturko, et al. (+5) Mahendra Jadhao, Yu-Li Chen, Tsong-Long Hwang, Fang-Rong Chang, Michal Korinek |
| 6 |
[GO] |
2025―Oct―28 |
Funicone-like compounds: potential antiviral agents towards canine coronavirus |
Maria Michela Salvatore, Luca Del Sorbo, Rosario Nicoletti, Marina DellaGreca, Valentina Iovane, Filomena Fiorito, Anna Andolfi |
| 7 |
[GO] |
2025―Oct―28 |
Application of feature based molecular network analysis for the investigation of the Covid-19 remedy Hanshiyi |
Stefanie Tiefenbacher, Eva-Maria Pferschy-Wenzig, Yanyan Zhou, Min Li, Xiaolin Tong, Rudolf Bauer |
| 8 |
[GO] |
2025―Jul―08 |
Isolation and computational characterization of a novel cyanogenic glucoside from Centaurea microcarpa with antiviral potential against SARS-CoV-2: DFT, ADMET, and molecular docking analysis |
Rachida Kerkour, Samia Baatouche, Abir Boublia, Nadjib Chafai, Ramadan Seghiri, Djamel Sarri |
| 9 |
[GO] |
2025―Jun―02 |
Utilizing natural compounds as ligands to disrupt the binding of SARS-CoV-2 receptor-binding domain to angiotensin-converting enzyme 2, impeding viral infection |
Jingyi Wu, Ting-Hsu Chen, Zi-han Shen, May-Jywan Tsai, Max K. Leong, Yan-qiang Huang, Ching-Feng Weng |
| 10 |
[GO] |
2025―May―31 |
Molecular docking and network pharmacology highlight salvianolic acids as potential inhibitors and therapeutic agents for COVID-19 treatment |
Anathi Msobo, Manamele Dannies Mashabela, Gerrit Koorsen, Teboho Nicolus Tsotetsi, Lizelle Ann Piater, Ntakadzeni Edwin Madala, et al. (+2) Tendamudzimu Tshiwawa, Msizi Innocent Mhlongo |
| 11 |
[GO] |
2024―Aug―13 |
Biodiversity and emergence of viral pandemics |
Bruno David |
| 12 |
[GO] |
2023―Jul―07 |
Structural characterization and SARS-CoV-2 inhibitory effects of alkaloids from the roots of Asarum heterotropoides var. mandshuricum (Aristolochiaceae) |
Thi Thanh Le, Thao Quyen Cao, Manh Tuan Ha, Kang-Hyun Han, Yong-Bum Kim, Jeong Ah Kim, Byung Sun Min |
| 13 |
[GO] |
2022―Aug―02 |
Synthesis and Evaluation of Diterpenic Mannich Bases as Antiviral Agents against Influenza A and SARS-CoV-2 |
Elena V. Tret’yakova, Xinyuan Ma, Oxana B. Kazakova, Anna A. Shtro, Galina D. Petukhova, Artem M. Klabukov, et al. (+4) Danil S. Dyatlov, Anna A. Smirnova, Huan Xu, Sulong Xiao |
